Gevorg Tamamyan, MD, Phd, MSc

Articles by Gevorg Tamamyan, MD, Phd, MSc

How to Treat Metastatic Malignant Triton Tumor in an Adolescent

ByIrina Melnichenko, MD,Lilit Sargsyan, MD,Karen Bedirian, MPH,Davit Dallakyan MD, PhD,Artak Gevorgyan, MD,Gevorg Aloyan, MD, PhD,Artur Harutyunyan, MD,Levon Davtyan, MD,Armine Lazaryan, MD,Narek Manukyan, MD,Gevorg Tamamyan, MD, Phd, MSc,Ruzanna Papyan, MD

November 21st 2022

A systematic review of reported clinical cases and treatment strategies was performed to better understand the prognostic factors and to develop the best possible treatment option for a 16-year-old patient diagnosed with a malignant triton tumor in the lower extremity with distant metastases in the lungs.

Opsoclonus-Myoclonus–Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?

ByMane Gizhlaryan, MD,Tigran Aghabekyan,Tatev Arakelyan, MPH,Meri Petrosyan, MD,Samvel Iskanyan, MD,Gevorg Tamamyan, MD, Phd, MSc,Lilit Sargsyan, MD,Ruzanna Papyan, MD

October 22nd 2021

In this clinical quandary, investigators determine how to best treat patients with opsoclonus-myoclonus–associated neuroblastoma with bone marrow metastases.

Pediatric Locally Advanced Synovial Sarcoma: What Would Be the Best Treatment Option?

ByMeri Petrosyan, MD,Anna Avagyan, MD,Shushan Hovsepyan, MD,Zaven Koloyan, MD,Gevorg Tamamyan, MD, Phd, MSc,Ruzanna Papyan, MD,Arianna Mesrobian, BA

February 11th 2021

KEY POINTS • Synovial sarcomas are often mistreated with unplanned tumor resection. • Attention from specialists early in the course of SS can minimize the risk of recurrence, metastases, and the necessity for resurgery, all of which are increased with unplanned tumor resection. • Chemotherapy alone does not provide sufficient local control of the tumor. • Resurgery, in conjunction with radiotherapy and chemotherapy, is the best choice of management for this patient.